2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
32
Gastrointestinal
24
Other hematologic neoplasm
13
Head & Neck
8
Thoracic
6
Lymphoid
5
Sarcoma
3
Plasma cell
3
Gynecologic
3
Classical hematology
3
Myeloid
2
Other neoplasm
1
Genitourinary
1
Dermatologic
1
Conditions
Sarcoma
1568
Glioblastoma
512
Gliosarcoma
485
Osteosarcoma
458
Brain Neoplasms
344
Gastrointestinal Stromal Tumors
324
Central Nervous System Neoplasms
296
Neoplasms
291
Dendritic Cell Sarcoma, Interdigitating
286
Astrocytoma
275
Lymphoma
259
Bone Neoplasms
243
Breast Neoplasms
237
Sarcoma, Ewing
236
Glioma
236
Neuroblastoma
230
Rhabdomyosarcoma
226
Melanoma
224
Precursor Cell Lymphoblastic Leukemia-Lymphoma
218
Recurrence
216
Lymphoma, Non-Hodgkin
216
Burkitt Lymphoma
213
Oligodendroglioma
203
Ovarian Neoplasms
200
Lymphoma, Large B-Cell, Diffuse
187
Neoplasm Metastasis
186
Lymphoma, Follicular
172
Leukemia
164
Leukemia, Lymphocytic, Chronic, B-Cell
158
Hodgkin Disease
158
Interventions
Standard of Care
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Transurethral Resection of Bladder
1
STA 9090
1
SGN-LIV1A
1
Paclitaxel
1
MK 2206
1
Letrozole
1
Lasofoxifene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Sarcoma
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled